CSTE
Caesarstone Ltd.
There isn't enough reported data to score CSTE yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CSTE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Weak |
CSTE's revenue, profitability, cash flow and balance sheet are all currently under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CSTE PE Valuation
CSTE has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CSTE Forward outlook
There aren't enough analyst estimates for CSTE to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CSTE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$4.12 | -$2.49 |
| Q1 2026 | -$4.21 | -$2.85 |
| Q4 2025 | -$3.97 | -$2.83 |
| Q3 2025 | -$2.03 | -$0.03 |
| Q2 2025 | -$1.63 | +$0.28 |
| Q1 2025 | -$1.36 | +$1.80 |
| Q4 2024 | -$1.14 | +$1.98 |
| Q3 2024 | -$2.00 | +$1.80 |
CSTE lost $4.12 per share over the past year, a bigger loss than the year before.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CSTE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $96.6M | -4.5% |
| Q1 2026 | $88.7M | -11% |
| Q4 2025 | $94.4M | -3.5% |
| Q3 2025 | $102.1M | -5.1% |
| Q2 2025 | $101.1M | -15% |
| Q1 2025 | $99.6M | -16% |
| Q4 2024 | $97.9M | -24% |
| Q3 2024 | $107.6M | -24% |
CSTE's revenue has slid since its 2022 peak: $97M last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5.6% | +4.9 points |
| Q1 2026 | -12% | +2.7 points |
| Q4 2025 | -18% | +5 points |
| Q3 2025 | -16% | -12 points |
| Q2 2025 | -11% | -2.8 points |
| Q1 2025 | -15% | -10 points |
| Q4 2024 | -23% | +2.4 points |
| Q3 2024 | -3.8% | -2.4 points |
CSTE has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CSTE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CSTE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.6M | +$15.1M |
| Q1 2026 | -$7.3M | +$9.4M |
| Q4 2025 | -$10.1M | -$4.9M |
| Q3 2025 | -$5.8M | -147% |
| Q2 2025 | -$13.5M | -261% |
| Q1 2025 | -$16.8M | -382% |
| Q4 2024 | -$5.2M | -148% |
| Q3 2024 | $12.4M | -48% |
CSTE has burned cash in six of the last eight quarters: −$22M over the past year, against −$23M the year before.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has the edge over CSTE on cash flow, with more consistent year-over-year improvement.
CSTE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +7.7K shares |
| 1 year | +0.1% | +24.9K shares |
| 3 years | +0.2% | +70.4K shares |
| 5 years | +0.1% | +44.9K shares |
| Available history | +0.4% | +142K shares |
CSTE has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CSTE hasn't bought back shares in the past year.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CSTE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2023 | 24.9x | High |
| Q1 2023 | 2.6x | Moderate |
| Q4 2022 | 2.5x | Moderate |
| Q3 2022 | 1.9x | Healthy |
| Q2 2022 | 1.7x | Healthy |
| Q1 2022 | 1.8x | Healthy |
| Q4 2021 | 1.8x | Healthy |
| Q3 2021 | 1.0x | Healthy |
CSTE's net debt is more than 20 years of its operating earnings (EBITDA), up from 1.7 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CSTE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.2 | Neutral |
| Stochastic | 4.9 | Oversold |
CSTE's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CSTE PE vs Industrials Sector
| Metric | CSTE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CSTE has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CSTE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.21 | 41% below |
| 20 week MA | $2.51 | 48% below |
| 50 week MA | $2.00 | 35% below |
| 100 week MA | $2.19 | 41% below |
| 200 week MA | $3.47 | 63% below |
CSTE is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CSTE on trend strength, trading above more of its moving averages.
CSTE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.9 | $11.0 | -26% |
| 2021 | $11.0 | $11.2 | +2.4% |
| 2022 | $11.2 | $5.83 | -48% |
| 2023 | $5.83 | $3.74 | -36% |
| 2024 | $3.74 | $4.42 | +18% |
| 2025 | $4.42 | $1.71 | -61% |
| 2026 YTD | $1.71 | $1.30 | -24% |
CSTE has finished lower in four of the last six years. It's down 24% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CSTE on returns for 2026, with the stronger performance.